BETABiohacksAI is a research tool for informational purposes only. All outputs are computational hypothesis candidates — not confirmed mechanisms, not medical advice, and not a substitute for professional medical judgment. Independent experimental validation is always required.
BiohacksAI is an evolving scientific literature platform. New compounds and evidence are indexed continuously.
B
○

Nitrendipine

A calcium channel blocker with marked vasodilator action. It is an effective antihypertensive agent and differs from other calcium channel blockers in that it does not reduce glomerular filtration rate and is mildly natriuretic, rather than sodium retentive.

299+ PubMed studies analyzed · 70 RCTs · Evidence Score: 50.4

Research Domains

Nitrendipine has been studied across 15 research domains including ❤️ Cardiovascular, 🦴 Bone & Joint, 🫘 Kidney, 🧠 Focus & Attention, 🔥 Metabolic. The primary research focus is ❤️ Cardiovascular with 50% of studies addressing this area.

Similar Compounds by Shared Targets

The following compounds share molecular targets with Nitrendipine, based on binding affinity data from BindingDB and ChEMBL. Sorted by shared target overlap.

Dexamethasone
9 shared targets
Prednisone
10 shared targets
Nisoldipine
20 shared targets
Doripenem
8 shared targets
Feprazone
10 shared targets
Meloxicam
9 shared targets
Stanozolol
10 shared targets
Betamethasone
10 shared targets
Phenylbutazone
10 shared targets
Delavirdine
8 shared targets
Loading evidence profile...

This evidence profile for Nitrendipine is generated deterministically from 299 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.

Data source: PubMed/MEDLINE (NLM). Corpus version: current. Patent pending (EVE-PAT-2026-001). © 2026 Organiq Sweden AB.